Skip to main content
Figure 1 | Molecular Cancer

Figure 1

From: Serum cytokine biomarker panels for discriminating pancreatic cancer from benign pancreatic disease

Figure 1

Classification of patients with PDAC vs. healthy control individuals. A. Feature finding showing the percentage occurrence of cytokines in models following resampling of training data for PDAC vs. Healthy Control. B.‚ÄČTraining set ROC Curves for PDAC vs. Healthy Control for a panel of IL-8, CA19-9 and IL-1b versus CA19-9 alone. C.‚ÄČTest set ROC curves for PDAC vs. Healthy Control for the panel of IL-8, CA19-9 and IL-1b versus CA19-9. D.‚ÄČThe resampling performance of the panel of IL-8, CA19-9 and IL-1b versus CA19-9 for the classification of PDAC vs. Healthy Control. The accuracies, sensitivities and specificities of the panel compared to CA19-9 alone over 100 patient-balanced resamples is shown. The quantiles of the performance indicators are summarised as boxplots with individual points superimposed and the significance of Friedman test comparisons is indicated (***p <0.001).

Back to article page